Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease

Neurobiology of Aging

Volumn 35, Issue 12, 2014, Pages 2665-2670

  Benedictus, Marije R ^a   Binnewijzend, Maja A A ^b   Kuijer, Joost P A ^b   Steenwijk, Martijn D ^b   Versteeg, Adriaan ^b   Vrenken, Hugo ^b   Scheltens, Philip ^a   Barkhof, Frederik ^b   van der Flier, Wiesje M ^a,b   Prins, Niels D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Arterial spin labeling; Cerebral blood flow; Cerebral small vessel disease; Neurodegeneration

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTERIAL SPIN LABELING; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN SIZE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NORMALIZED BRAIN VOLUME; SPIN LABELING; WHITE MATTER HYPERINTENSITY; BRAIN; BRAIN CIRCULATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; VASCULARIZATION; WHITE MATTER;

AGED; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; WHITE MATTER;

EID: 84911365227     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.06.001     Document Type: Article

References (40)

1. Alexopoulos P., Sorg C., Forschler A., Grimmer T., Skokou M., Wohlschlager A., Perneczky R., Zimmer C., Kurz A., Preibisch C. Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI. Eur. Arch. Psychiatry Clin. Neurosci. 2012, 1:69-77.
2. Alsop D.C., Casement M., de Bazelaire C., Fong T., Press D.Z. Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage 2008, 4:1267-1274.
3. Alsop D.C., Dai W., Grossman M., Detre J.A. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J.Alzheimers. Dis. 2010, 3:871-880.
4. Anbeek P., Vincken K.L., Viergever M.A. Automated MS-lesion segmentation by k-nearest neighbor classification. MIDAS J. 2008, 1-8.
5. Appelman A.P., van der Graaf Y., Vincken K.L., Tiehuis A.M., Witkamp T.D., Mali W.P., Geerlings M.I. Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study. J.Cereb. Blood Flow Metab. 2008, 3:633-639.
6. Asllani I., Borogovac A., Brown T.R. Regression algorithm correcting for partial volume effects in arterial spin labeling MRI. Magn. Reson. Med. 2008, 6:1362-1371.
7. Barnes J.N., Taylor J.L., Kluck B.N., Johnson C.P., Joyner M.J. Cerebrovascular reactivity is associated with maximal aerobic capacity in healthy older adults. J.Appl. Physiol. (1985) 2013, 10:1383-1387.
8. Bastos-Leite A.J., Kuijer J.P., Rombouts S.A., Sanz-Arigita E., van Straaten E.C., Gouw A.A., van der Flier W.M., Scheltens P., Barkhof F. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am. J. Neuroradiol. 2008, 7:1296-1301.
9. Binnewijzend M.A., Kuijer J.P., Benedictus M.R., van der Flier W.M., Wink A.M., Wattjes M.P., van Berckel B.N., Scheltens P., Barkhof F. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 2013, 1:221-230.
10. Brickman A.M., Honig L.S., Scarmeas N., Tatarina O., Sanders L., Albert M.S., Brandt J., Blacker D., Stern Y. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch. Neurol. 2008, 9:1202-1208.
11. Buxton R.B., Frank L.R., Wong E.C., Siewert B., Warach S., Edelman R.R. Ageneral kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn. Reson. Med. 1998, 3:383-396.
12. Chard D.T., Jackson J.S., Miller D.H., Wheeler-Kingshott C.A. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J.Magn Reson. Imaging 2010, 1:223-228.
13. Dai W., Garcia D., de Bazelaire C., Alsop D.C. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn. Reson. Med. 2008, 6:1488-1497.
14. Dai W., Lopez O.L., Carmichael O.T., Becker J.T., Kuller L.H., Gach H.M. Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009, 3:856-866.
15. Geerlings M.I., Jonker C., Bouter L.M., Ader H.J., Schmand B. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am. J. Psychiatry 1999, 4:531-537.
16. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 1:119-128.
17. Jenkinson M., Smith S. Aglobal optimisation method for robust affine registration of brain images. Med. Image Anal. 2001, 2:143-156.
18. Kimura N., Nakama H., Nakamura K., Aso Y., Kumamoto T. Effect of white matter lesions on brain perfusion in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2012, 3-4:256-261.
19. Luckhaus C., Cohnen M., Fluss M.O., Janner M., Grass-Kapanke B., Teipel S.J., Grothe M., Hampel H., Peters O., Kornhuber J., Maier W., Supprian T., Gaebel W., Modder U., Wittsack H.J. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res. 2010, 1:44-51.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 7:939-944.
21. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers. Dement. 2011, 3:263-269.
22. Mulder C., Verwey N.A., van der Flier W.M., Bouwman F.H., Kok A., van Elk E.J., Scheltens P., Blankenstein M.A. Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin. Chem. 2010, 2:248-253.
23. Petersen E.T., Zimine I., Ho Y.C., Golay X. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br. J. Radiol. 2006, 944:688-701.
24. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M. ABayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011, 3:907-922.
25. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 9:1133-1142.
26. Popescu V., Battaglini M., Hoogstrate W.S., Verfaillie S.C., Sluimer I.C., van Schijndel R.A., van Dijk B.W., Cover K.S., Knol D.L., Jenkinson M., Barkhof F., de Stefano N., Vrenken H. Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis. Neuroimage 2012, 4:1484-1494.
27. Scheltens P., Barkhof F., Leys D., Wolters E.C., Ravid R., Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995, 5:883-888.
28. Schuff N., Matsumoto S., Kmiecik J., Studholme C., Du A., Ezekiel F., Miller B.L., Kramer J.H., Jagust W.J., Chui H.C., Weiner M.W. Cerebral blood flowin ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers. Dement. 2009, 6:454-462.
29. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 3:143-155.
30. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Kaye J., Montine T.J., Park D.C., Reiman E.M., Rowe C.C., Siemers E., Stern Y., Yaffe K., Carrillo M.C., Thies B., Morrison-Bogorad M., Wagster M.V., Phelps C.H. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers. Dement. 2011, 3:280-292.
31. Steenwijk M.D., Pouwels P.J., Daams M., van Dalen J.W., Caan M.W., Richard E., Barkhof F., Vrenken H. Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs). Neuroimage Clin. 2013, 3:462-469.
32. van der Flier W.M., Middelkoop H.A., Weverling-Rijnsburger A.W., Admiraal-Behloul F., Spilt A., Bollen E.L., Westendorp R.G., van Buchem M.A. Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology 2004, 10:1862-1864.
33. van Es A.C., van der Grond J., ten Dam V., de Craen A.J., Blauw G.J., Westendorp R.G., Admiraal-Behloul F., van Buchem M.A. Associations between total cerebral blood flow and age related changes of the brain. PLoS One 2010, 3:e9825.
34. van Gelderen P., de Zwart J.A., Duyn J.H. Pittfalls of MRI measurement of white matter perfusion based on arterial spin labeling. Magn. Reson. Med. 2008, 4:788-795.
35. van Osch M.J., Teeuwisse W.M., van Walderveen M.A., Hendrikse J., Kies D.A., van Buchem M.A. Can arterial spin labeling detect white matter perfusion signal?. Magn. Reson. Med. 2009, 1:165-173.
36. Vernooij M.W., van der Lugt A., Ikram M.A., Wielopolski P.A., Vrooman H.A., Hofman A., Krestin G.P., Breteler M.M. Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study. J.Cereb. Blood Flow Metab. 2008, 2:412-419.
37. Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R., Lindley R.I., O'Brien J.T., Barkhof F., Benavente O.R., Black S.E., Brayne C., Breteler M., Chabriat H., Decarli C., de Leeuw F.E., Doubal F., Duering M., Fox N.C., Greenberg S., Hachinski V., Kilimann I., Mok V., Oostenbrugge Rv, Pantoni L., Speck O., Stephan B.C., Teipel S., Viswanathan A., Werring D., Chen C., Smith C., van Buchem M., Norrving B., Gorelick P.B., Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013, 8:822-838.
38. Wolk D.A., Detre J.A. Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Curr. Opin. Neurol. 2012, 4:421-428.
39. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 2001, 1:45-57.
40. Zhang Q., Stafford R.B., Wang Z., Arnold S.E., Wolk D.A., Detre J.A. Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease. J.Alzheimers. Dis. 2012, 3:677-687.